retatrutide nash trial FDA Approves First Drug & Other Pipelines in Clinical Trials Retatrutide: Benefits, Mechanism & Research

Keep it on a middle shelf, not the door and not the freezer

Oral semaglutide has proven to be noninferior to placebo in high-risk patients in a pre-approval study (30), and a larger trial to evaluate the long-term cardiovascular benefit of oral semaglutide is ongoing (NCT03914326)

The EU5 public healthcare systems also reimburse GLP-1s, but often with prescribing restrictions such as specialist approval or use only as 3rd line treatment at the earliest, which limits penetration

Yes ra Medical Clinic is a telehealth-only practice

No prior appointment is required

[DOI] [PMC free article] [PubMed] [Google Scholar] Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, et al